Advancing Regenerative & Cellular Medicine Across Asia

CellBridge at a glance

Breakthrough Cell-Based Therapies, Delivered Responsibly

CellBridge Health partners with leading Japanese and global innovators in cellular and regenerative medicine to bring clinically validated, low-toxicity immune-cell therapies to high-need markets across Asia. 

Our mission is to safely accelerate patient access to proven therapeutic innovations, beginning with Japan-validated autologous activated αβ T-cell immunotherapy for cancer care.

How our therapy works

Our therapy uses a patient’s own T-cells, collected and activated outside the body, then reinfused to enhance immune surveillance against residual cancer cells. 

The approach is designed to improve disease-free survival while maintaining a favourable safety profile compared with traditional adjuvant options.

Key characteristics:

  • Patient-derived, cell-based treatment
  • Ex-vivo activation and expansion of αβ T-cells
  • Intended to reduce relapse risk after surgery
  • Built on real-world clinical experience in Japan

Our focus

Clinical Translation
We bridge world-class Japanese clinical evidence into Asia through regulated bridging trials, ensuring the highest global standards of safety, GMP manufacturing, and clinical oversight.

Licensed Treatment Platforms
We establish the region’s first licensed platforms for cell-based cancer therapies, enabling hospitals to deliver effective, low-toxicity immunotherapies within their existing infrastructure.

Global Partnerships
In collaboration with Japan’s leading immune-cell therapy groups, including Kiwa and partner research institutes, we transfer validated clinical protocols, GMP SOPs, and supervisory expertise directly into local health ecosystems.

Investment & Infrastructure
We deploy strategic investment and operational capability to build sustainable regional capacity across GMP manufacturing facilities, clinical trial networks, localised training programs, and long-term therapeutic pipelines.


Our team

Our team is driven by purpose and supported by a leadership group that proudly champions a balanced, collaborative approach. Together, we are advancing the proprietary activated αβ T-cell immunotherapy. We are working to bring a clinically proven therapy into new healthcare systems, combining global expertise, scientific rigour, and a shared commitment to improving patient outcomes.

"Our team works with global partners to advance innovative, clinically proven T-cell therapies and bring balanced, meaningful progress to patients and healthcare systems worldwide."

20+ years in health, finance, and cross-border partnerships. Leads international investment and medical innovation initiatives across Asia and Australia, translating technology into scalable healthcare ventures.

Dr Stephen Moss

Co-Founder & Chair

Experienced fund manager and strategist with deep expertise in capital markets, infrastructure, and healthcare. Oversees CellBridge’s financial strategy, operations, and governance.

Scott Roantree

Co-Founder & CEO

We’re fortunate to collaborate with exceptional partners to support improved outcomes for patients following surgery.

Partners

We work closely with:

If you are interested in collaborating with CellBridge Health, we welcome the opportunity to connect.

CellBridge Health

 ​ Australia

Lead sponsor, IP holder, governance, capital management

Bioaccell Inc.

 ​ Japan

Technology transfer, SOPs, QC training, CPC supervision

AMTZ / BVIC

 ​ India

Infrastructure, staff, regulatory facilitation, GMP certification.

Hospital Partner (e.g., KIMS)

Patient recruitment, treatment delivery, follow-up data

Seta Clinic Tokyo

 ​ Japan

Clinical training, treatment protocol oversight

Eaton Capital Partners

 ​ Australia

Fundraising and investment structuring 

Powered by
►
Necessary cookies enable essential site features like secure log-ins and consent preference adjustments. They do not store personal data.
None
►
Functional cookies support features like content sharing on social media, collecting feedback, and enabling third-party tools.
None
►
Analytical cookies track visitor interactions, providing insights on metrics like visitor count, bounce rate, and traffic sources.
None
►
Advertisement cookies deliver personalized ads based on your previous visits and analyze the effectiveness of ad campaigns.
None
Powered by